Loading data
ACCONYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.52 bn USD | 1.67 bn USD | 1.83 bn USD | 1.95 bn USD | 2.03 bn USD |
| Cost of revenue | 1.02 bn USD | 1.11 bn USD | 1.23 bn USD | 1.4 bn USD | 1.41 bn USD |
| Gross profit | 500 m USD | 555.4 m USD | 598.3 m USD | 552.3 m USD | 614.9 m USD |
| Research and development expense | 22 m USD | 23 m USD | 25.8 m USD | 26.3 m USD | 26.6 m USD |
| Selling, general and administrative expense | 346.7 m USD | 365.7 m USD | 393.5 m USD | 376.7 m USD | 392.6 m USD |
| Operating profit | 92.3 m USD | -37 m USD | 44.7 m USD | 34.8 m USD | 151 m USD |
| Interest expense | 45.8 m USD | 52.6 m USD | 58.6 m USD | 45.6 m USD | 46.3 m USD |
| Profit before tax | 49.1 m USD | -87.3 m USD | -13.1 m USD | 14.9 m USD | 111.4 m USD |
| Income tax expense | 7.8 m USD | 14.3 m USD | 8.7 m USD | 28.1 m USD | 9.5 m USD |
| Net income (reported basis) | 41.3 m USD | -101.6 m USD | -21.8 m USD | -13.2 m USD | 101.9 m USD |
| Basic earnings per share | 0.45 USD/share | -1.06 USD/share | -0.23 USD/share | -0.14 USD/share | 1.07 USD/share |
| Diluted earnings per share | 0.44 USD/share | -1.06 USD/share | -0.23 USD/share | -0.14 USD/share | 1.05 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.